Harvard Pulmonary and Critical Care Medicine 2023
OVERVIEW
- Post-acute sequelae of COVID-19
- Chronic cough
- COPD
- Asthma
- Lung nodules
- Lung cancer
- Sleep-disordered breathing
- GERD
- Sepsis
- ARDS
- Sarcoidosis
- IPF
- Pleural disease
- Pneumonia
- Tuberculosis
- Surgical emergencies
- Thromboembolism
- Lung transplantation
- Neurologic issues in the ICU
- Septic shock
- Interstitial lung disease
- Bronchiectasis
- Cystic fibrosis
- Atypical mycobacterial disease
- Pulmonary hypertension
- Cardiopulmonary disorders
- Complications from cardiac arrest
- Hypersensitivity pneumonitis
- Occupational and environmental lung disease
- Acute respiratory failure
- Vaping-related lung disease
- Hemorrhage and ANCA-associated disease
REASONS TO ATTEND IN 2023
- COVID-19, PASC, and emerging diseases
- Advanced techniques in interventional pulmonology
- High-flow oxygen therapy for respiratory failure
- New biologics for asthma
- Lung microbiome: emerging implications for lung health
- Emerging evidence for targeted temperature management
- Evaluating occupational and environmental lung disease
- Prescribing medications for interstitial lung disease
- Pulmonary embolus: the latest treatment strategies
- State-of-the-art management of the critically ill patient
- Guidance to conduct end-of-life discussions
- Updates in pulmonary pathology
- New treatment options in cystic fibrosis
- Handling neurologic and surgical emergencies in the medical ICU
- The state of the art in interventional bronchoscopy
- The most current guidelines for treating sepsis
- Evidence-based treatment of ARDS
- Updates on vaping-related lung disease
- New therapeutics in the age of immunology
- Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest prognosis
- New approaches that improve outcomes for patients with unexplained chronic cough
- Current guidelines for management of pulmonary nodules
- Targeted therapies and immunotherapies for lung cancer
- When to consider lung transplantation and eligibility
- When and how to use the newest drugs in IPF
- Expert advice on atypical mycobacterial diagnostics and therapy
- New concepts in the use of vasopressors in septic shock
- New drugs and combinations in pulmonary hypertension
- New evidence on sedation, analgesia, and early mobility
- Point-of-care pulmonary ultrasound in the intensive care unit